Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (9): 928-931    DOI: 10.19485/j.cnki.issn2096-5087.2022.09.013
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
脂质蓄积指数和内脏脂肪指数筛查中老年人群代谢综合征研究
王倩倩, 曲淑娜, 于绍轶, 张红杰
烟台市疾病预防控制中心慢性非传染病防制科,山东 烟台 264003
Predictive value of lipid accumulation product and visceral fat index for metabolic syndrome among middle-aged and elderly populations
WANG Qianqian, QU Shuna, YU Shaoyi, ZHANG Hongjie
Department of Non-communicable Disease Control and Prevention, Yantai Center for Disease Control and Prevention, Yantai, Shandong 264003, China
全文: PDF(799 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 评估脂质蓄积指数(LAP)和内脏脂肪指数(VAI)筛查代谢综合征(MS)的价值。方法 基于2018年山东省烟台市慢性病及危险因素调查,收集≥45岁人群的年龄、疾病史、腰围(WC)、体质指数(BMI)、血压和血脂资料,计算LAP和VAI。分别采用国际多机构关于MS定义的联合声明(JIS标准)和中华医学会糖尿病分会推荐标准(CDS标准)诊断MS,绘制受试者操作特征(ROC)曲线评估LAP和VAI筛查MS的价值。结果 纳入9 366人,年龄为(59.49±9.73)岁。男性4 340人,占46.34%;女性5 026人,占53.66%。按照CDS标准诊断,MS患病率为24.58%;LAP和VAI筛查MS的曲线下面积(AUC)分别为0.837(95%CI:0.828~0.846)和0.751(95%CI:0.739~0.762),灵敏度分别为78.82%和63.31%,最佳截断值分别为44.64和1.86。按照JIS标准诊断,MS患病率为35.26%;LAP和VAI筛查MS的AUC值分别为0.842(95%CI:0.834~0.850)和0.790(95%CI:0.780~0.800),灵敏度分别为75.73%和68.42%,最佳截断值分别为42.01和1.67。结论 LAP和VAI筛查中老年人群MS的准确性较好,LAP要优于VAI。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
王倩倩
曲淑娜
于绍轶
张红杰
关键词 脂质蓄积指数内脏脂肪指数代谢综合征中老年人群    
AbstractObjective To investigate the value of lipid accumulation product (LAP) and visceral fat index (VAI) for prediction of metabolic syndrome (MS). Methods Based on the 2018 Survey on Chronic Diseases and Risk Factors in Yantai City of Shandong Province, residents at ages of 45 years and older were sampled, and subjects' age, disease history, waist circumstance (WC), body mass index (BMI), blood pressure and blood lipid were collected to calculate LAP and VAI. MS was diagnosed with the a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity (JIS definition) and the recommended criteria proposed by the Chinese Diabetes Society (CDS) of Chinese Medical Association (CDS criteria), and the values of LAP and VAI for MS screening were evaluated using the receiver operating characteristic (ROC) curve analysis. Results Totally 9 366 subjects were enrolled, including 4 340 men (46.34%) and 5 026 women (53.66%), and had a mean age of (54.49±9.73) years. According to the CDS criteria, the prevalence of MS was 24.58%, and LAP and VAI showed areas under the ROC curve (AUC) of 0.837 (95%CI: 0.828-0.846) and 0.751 (95%CI: 0.739-0.762), sensitivities of 78.82% and 63.31% and optimal cut-off values of 44.64 and 1.86 for screening of MS. According to the JIS definition, the prevalence of MS was 35.26%, and LAP and VAI showed AUC values of 0.842 (95%CI: 0.834-0.850) and 0.790 (95%CI: 0.780-0.800), sensitivities of 75.73% and 68.42% and optimal cut-off values of 42.01 and 1.67 for screening of MS. Conclusions Both LAP and VAI are effective for screening MS among middle-aged and elderly residents, and LAP presents a higher accuracy than VAI.
Key wordslipid accumulation product    visceral fat index    metabolic syndrome    middle-aged and elderly people
收稿日期: 2022-04-28      修回日期: 2022-06-23     
中图分类号:  R195  
基金资助:山东省医药卫生科技发展计划项目(202012050192)
通信作者: 张红杰,E-mail:zhjhoiane061@163.com   
作者简介: 王倩倩,硕士,主管医师,主要从事慢性病防制工作
引用本文:   
王倩倩, 曲淑娜, 于绍轶, 张红杰. 脂质蓄积指数和内脏脂肪指数筛查中老年人群代谢综合征研究[J]. 预防医学, 2022, 34(9): 928-931.
WANG Qianqian, QU Shuna, YU Shaoyi, ZHANG Hongjie. Predictive value of lipid accumulation product and visceral fat index for metabolic syndrome among middle-aged and elderly populations. Preventive Medicine, 2022, 34(9): 928-931.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.09.013      或      http://www.zjyfyxzz.com/CN/Y2022/V34/I9/928
[1] 何宇纳,赵文华,赵丽云,等.中国2010—2012年成年人代谢综合征流行特征[J].中华流行病学杂志,2017,38(2):212-215.
HE Y N,ZHAO W H,ZHAO L Y,et al.Prevalence of metabolic syndrome in Chinese adults in 2010-2012[J].Chin J Epidemiol,2017,38(2):212-215.
[2] 李文敏,高凯.2014—2017年我国居民代谢综合征患病率的meta分析[J].慢性病学杂志,2018,19(11):1476-1480.
LI W M,GAO K.The prevalence of metabolic syndrome in China from 2014 to 2017:a meta-analysis[J].Chronic Pathematol J,2018,19(11):1476-1480.
[3] 孙焕珍,金来润,左翔,等.社区体检人群代谢综合征患病情况及相关影响因素的调查分析[J].中华疾病控制杂志,2017,21(5):465-468.
SUN H Z,JIN L R,ZUO X,et al.Study on the prevalence of metabolic syndrome and its influencing factors in a community medical check-up crowd[J].Chin J Dis Control Prev,2017,21(5):465-468.
[4] 朱雯,李辉,王永,等.宁波市居民代谢综合征现况调查[J].预防医学,2017,29(7): 653-659.
ZHU W,LI H,WANG Y,et al.A study on the prevalence of metabolic syndrome and related factors among residents in Ningbo[J].Prev Med,2017,29(7):653-659.
[5] 刘晨,张黎军.新型体脂指数脂质蓄积指数和内脏脂肪指数的相关研究进展[J].中国糖尿病杂志,2016,24(11):1032-1035.
LIU C,ZHANG L J.Research progress of new type body fat indexes of lipid accumulation product index and visceral adiposity index[J].Chin J Diabetes,2016,24(11):1032-1035.
[6] 蔡瑞雪,巢健茜,孔玲燕,等.四种代谢综合征诊断标准在老年人中的适用性比较[J].中华疾病控制杂志,2019,23(2):146-149.
CAI R X,CHAO J X,KONG L Y,et al.Comparison of four different metabolic syndrome diagnostic criteria among the elderly in Nanjing[J].Chin J Dis Control Prev,2019,23(2):146-149.
[7] ALBERTI K G,ECKEL R H,GRUNDY S M,et al.Harmonizing the metabolic syndrome:a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute;American Heart Association; World Heart Federation; International Atherosclerosis Society;and International Association for the Study of Obesity[J].Circulation,2009,120(16):1640-1645.
[8] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020 年版)[J].中华糖尿病杂志,2021,13(4):315-409.
Chinese Diabetes Society.Guidelines for the prevention and control of type 2 diabetes in China (2020 editon)[J].Chin J Diabetes Mellit,2021,13(4):315-409.
[9] 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419.
Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults.Chinese guidelines on prevention and treatment of dyslipidemia in adults[J].Chin J Cardiol,2007,35(5):390-419.
[10] 王超伟,张洁,梁屹,等.石家庄市中老年代谢综合征现状及其相关因素分析的调查研究[J].中国糖尿病杂志,2013,21(5):398-401.
WANG C W,ZHANG J,LIANG Y,et al.Epidemiological investigation on metabolic syndrome in middle-aged and old people in Shijiazhuang and analysts on its influence factors[J].Chin J Diabetes,2013,21(5):398-401.
[11] 李望. 成都市中老年人代谢综合征患病情况及其危险因素分析[J].中国公共卫生,2021,37(1):40-43.
LI W.Prevalence and risk factors of metabolic syndrome among middle-aged and elderly people in Chengdu city[J].Chin J Public Health,2021,37(1):40-43.
[12] 黄长珍,卢章云,胡引闹,等.东阳市居民代谢综合征患病现况调查[J].预防医学,2016,28(5):490-492.
HUANG C Z,LU Z Y,HU Y N,et al.The prevalence of metabolic syndrome among residents in Dongyang City[J].Prev Med,2016,28(5):490-492.
[13] MOTAMED N,KHONSARI M R,RABIEE B,et al.Discriminatory ability of visceral adiposity index(VAI)in diagnosis of metabolic syndrome:a population based study[J].Exp Clin Endocrinol Diabetes,2017,125(3):202-207.
[14] CHENG Y L,WANG Y J,LAN K H,et al.Fatty liver index and lipid accumulation product can predict metabolic syndrome in subjects without fatty liver disease[J/OL].Gastroenterol Res Pract,2017[2022-06-23].https://doi.org/10.1155/2017/9279836.
[15] 陆春华,仇琦,董爱丽,等.上海郊县社区中老年人代谢综合征调查及影响因素分析[J].中华老年心脑血管病杂志,2021,23(10):1095-1096.
LU C H,QIU Q,DONG A L,et al.Prevalence of metabolic syndrome and its influencing factors among the middle aged and old populations in suburban communities of Shanghai[J].Chin J Geriatr Heart Brain Vessel Dis,2021,23(10):1095-1096.
[16] 蒋剑波,林玲萍,杜丽云,等.杭州市中年人群三种膳食模式与代谢综合征的关系研究[J].预防医学,2018,30(12): 1222-1226.
JIANG J B,LIN L P,DU L Y,et al.Association of three dietary patterns with metabolic syndrome in the middle-aged population in Hangzhou[J].Prev Med,2018,30(12):1222-1226.
[17] 喻森海,潘飞霞,顾杭杰,等.农村代谢综合征患者强化生活方式干预效果评价[J].预防医学,2017,29(12):1193-1198.
YU S H,PAN F X,GU H J,et al.Effectiveness evaluation of intensive lifestyle intervention on rural residents with metabolic syndrome[J].Prev Med,2017,29(12):1193-1198.
[1] 王倩倩, 刘海韵, 于绍轶, 曲淑娜, 张红杰. 中老年人群2型糖尿病与骨质疏松发病的竞争风险研究[J]. 预防医学, 2021, 33(11): 1136-1138.
[2] 贾成静, 沈郁, 苏丹婷, 王蒙, 黄李春, 胡崇高. 浙江省居民膳食烟酸摄入量与代谢综合征的关联研究[J]. 预防医学, 2021, 33(10): 973-976,982.
[3] 吴霞, 陆建林, 翁根龙. 老年代谢综合征患者尿酸、B型脑钠肽和超敏C反应蛋白水平分析[J]. 预防医学, 2019, 31(1): 59-61.
[4] 李江峰,潘优津,苏小游,郑超,郑艳容,苏依所,倪秀程. 温州市成人隐匿性自身免疫糖尿病调查结果[J]. 预防医学, 2018, 30(8): 827-829.
[5] 蒋剑波, 林玲萍, 杜丽云, 郑培奋. 杭州市中年人群三种膳食模式与代谢综合征的关系研究[J]. 预防医学, 2018, 30(12): 1222-1225,1230.
[6] 周攀, 蒋丹, 郑睿智, 朱益民. 肾功能轻度下降与代谢综合征及其组分的关系[J]. 预防医学, 2017, 29(8): 786-789.
[7] 朱雯, 李辉, 王永, 崔军, 应焱燕, 李思萱, 朱银潮, 陈洁平, 龚清海, 张涛. 宁波市居民代谢综合征现况调查[J]. 预防医学, 2017, 29(7): 653-659.
[8] 朱幸, 朱益民, 张思潮. 不同体型人群代谢状况分析[J]. 预防医学, 2017, 29(5): 489-492,495.
[9] 喻森海,潘飞霞,顾杭杰,瞿琼,翟利君,郭灿安,徐春晓,周丹,杨敏,朱益民. 农村代谢综合征患者强化生活方式干预效果评价[J]. 预防医学, 2017, 29(12): 1193-1198.
[10] 苏依所,倪建晓,吴文秀,郑剑勇,黄秀敏,郑建浜. 瓯海区居民血尿酸水平与代谢综合征相关性分析[J]. 预防医学, 2016, 28(7): 702-705.
[11] 黄长珍,卢章云,胡引闹,陈宵,陈晓伟,张美君,倪丽萍,洪妙兰. 东阳市居民代谢综合征患病现况调查[J]. 预防医学, 2016, 28(5): 490-492.
[12] 范佳莹, 李向明, 陈长喜, 毛玉山. 宁波市中老年人甲状腺结节患病状况调查[J]. 预防医学, 2016, 28(5): 495-497.
[13] 董芬, 江志琴, 蒋长征, 王勍. 城市社区中老年人群健康管理需求及影响因素分析[J]. 预防医学, 2016, 28(12): 1189-1192.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed